TOPLINE:  In real-world settings, tirzepatide leads to substantial weight loss; however, patients who have already lost weight prior to initiation experience smaller additional reductions than those […]

TOPLINE: AI-based screening paired with transient elastography was cost-effective for detecting advanced liver fibrosis in at-risk adults with metabolic dysfunction-associated steatotic liver disease (MASLD), particularly when […]

TOPLINE: Predictive models with patient-reported psychosocial measures added to clinical data achieved better predictive performance for flares in patients with inflammatory bowel disease (IBD) than models […]

TOPLINE: Patients who experienced infectious enteritis had a significantly increased risk of developing irritable bowel syndrome (IBS) and functional dyspepsia, alongside elevated healthcare use, and the […]

TOPLINE:  Among patients with obesity and type 2 diabetes (T2D) who underwent general surgery, prior metabolic bariatric surgery (MBS) was associated with lower odds of postoperative […]

TOPLINE: Among patients with ulcerative colitis (UC) after vedolizumab failure, infliximab, subcutaneous anti-TNF agents, and ustekinumab demonstrated comparable effectiveness and treatment persistence as second-line therapies. METHODOLOGY: […]

TOPLINE: Patients newly diagnosed with inflammatory bowel disease (IBD) had higher proportions of anxiety and depressive symptoms than the general population and showed sex differences. Substantial […]